D-1036-2017 Class II Terminated
FDA drug recall D-1036-2017 was initiated by Apace KY LLC on Jun 19, 2017 and is designated Class II. Reason for recall: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg The recall status is terminated (terminated May 4, 2018).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2017
- Initiation Date
- Jun 19, 2017
- Termination Date
- May 4, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15
Reason for recall
Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg
Distribution pattern
KY
Code information
Lot: 16710, exp 07/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1036-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026